Clinical Trial Update: A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A pilot study of curcumin and Ginkgo biloba for Alzheimer's disease has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Curcumin (curcumin)
• Ginkgo biloba (Ginkgo biloba)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED